Ignite Creation Date:
2024-05-06 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05730712
Status:
RECRUITING
Last Update Posted:
2024-03-12
First Post:
2023-02-07
Brief Title:
Pertuzumab Trastuzumab Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-08
Start Date Type:
ACTUAL
Primary Completion Date:
2025-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-10
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-07
First Submit QC Date:
February 7 2023
Study First Post Date:
2023-02-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-08
Last Update Post Date:
2024-03-12
Last Update Post Date Type:
ACTUAL